Clinical role of positron emission tomography in oncology
- PMID: 11902566
- DOI: 10.1016/s1470-2045(00)00257-6
Clinical role of positron emission tomography in oncology
Abstract
Positron emission tomography (PET) is now in routine use in oncology, through the success of metabolic imaging, mainly with fluorodeoxyglucose (FDG). Clear benefit is obtained with FDG PET in the assessment of patients with recurrent or residual disease, especially colorectal cancer and lymphoma. Preoperative staging of non-small-cell lung cancer with FDG PET is of proven benefit. Staging and restaging of patients with melanoma of stage II or greater is useful, and FDG PET has also been successfully used to investigate single pulmonary nodules. Tumour grading has been assessed, especially in the brain, but an important and emerging indication is the evaluation of tumour response with PET. Rapid decline of FDG uptake has been observed in responsive cancers. Further advances are being made with other fluorine-18-labelled and generator-based PET tracers, the only ones that can be used in units without dedicated cyclotrons.
Similar articles
-
[Cost-effective PET scans in oncology].Orv Hetil. 2002 May 26;143(21 Suppl 3):1255-61. Orv Hetil. 2002. PMID: 12077909 Review. Hungarian.
-
[Positron-emission tomography in oncology].Klin Med (Mosk). 2003;81(12):13-21. Klin Med (Mosk). 2003. PMID: 14971150 Review. Russian.
-
[Positron emission tomography (PET) and (F-18)-fluorodeoxyglucose in (FDG) in cancerology].Bull Cancer. 1998 Nov;85(11):935-50. Bull Cancer. 1998. PMID: 9951421 French.
-
[Cost-effective PET investigations in oncology].Magy Onkol. 2002;46(3):203-23. Epub 2002 Oct 6. Magy Onkol. 2002. PMID: 12368917 Review. Hungarian.
-
[A proposal for the rational use of the PET in oncology].Rev Esp Med Nucl. 2002 May;21(3):163-73. doi: 10.1016/s0212-6982(02)72056-9. Rev Esp Med Nucl. 2002. PMID: 12206749 Review. Spanish.
Cited by
-
Gastric cancers with microsatellite instability exhibit high fluorodeoxyglucose uptake on positron emission tomography.Gastric Cancer. 2013 Apr;16(2):185-92. doi: 10.1007/s10120-012-0165-2. Epub 2012 Jun 13. Gastric Cancer. 2013. PMID: 22692466
-
Gastric schwannomas show an obviously increased fluorodeoxyglucose uptake in positron emission tomography: report of two cases.Surg Today. 2011 Aug;41(8):1133-7. doi: 10.1007/s00595-010-4401-2. Epub 2011 Jul 20. Surg Today. 2011. PMID: 21773906
-
Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine.Nucl Med Biol. 2020 Jul-Aug;86-87:20-29. doi: 10.1016/j.nucmedbio.2020.03.006. Epub 2020 Apr 3. Nucl Med Biol. 2020. PMID: 32447069 Free PMC article.
-
Imaging peritoneal metastasis of gastric cancer with 18F-fluorothymidine positron emission tomography/computed tomography: a proof-of-concept study.Br J Radiol. 2018 Sep;91(1089):20180259. doi: 10.1259/bjr.20180259. Epub 2018 Jun 27. Br J Radiol. 2018. PMID: 29916721 Free PMC article.
-
Clinical Value of a One-Stop-Shop Low-Dose Lung Screening Combined with (18)F-FDG PET/CT for the Detection of Metastatic Lung Nodules from Colorectal Cancer.Nucl Med Mol Imaging. 2016 Jun;50(2):144-9. doi: 10.1007/s13139-015-0387-4. Epub 2015 Dec 17. Nucl Med Mol Imaging. 2016. PMID: 27275363 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources